Voltar
Carta Acesso aberto Revisado por pares
BIBTEX RIS

Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending

2019; AlphaMed Press; Volume: 25; Issue: 2 Linguagem: Inglês

10.1634/theoncologist.2019-0467

ISSN

1549-490X

Autores

Ariadna Ortiz‐Brugués, V. Sibaud, Béatrice Herbault‐Barres, Sarah Bétrian, Iphigénie Korakis, Caroline de Bataille, Carlos Gomez‐Roca, Joel B. Epstein, Émmanuelle Vigarios,

Tópico(s)

Oral Health Pathology and Treatment

Resumo

Commenting on a recently published article on sicca syndrome linked to immune checkpoint inhibitor therapy, this letter to the editor shares another viewpoint on the management of this immune-related adverse event.

Referência(s)